H. Ralph Snodgrass - PRES./CHIEF SCIENTIFIC OFFICER at Vistagen Therapeutics, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	65K	$112K	$1.72	Dec 31, 2021	Direct
Common Stock	33.9K	$58.2K	$1.72	Dec 31, 2021	By H. Ralph Snodgrass Living Trust, dated 10/2/2008

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.